ebselen has been researched along with Brain Vascular Disorders in 1 studies
ebselen : A benzoselenazole that is 1,2-benzoselenazol-3-one carrying an additional phenyl substituent at position 2. Acts as a mimic of glutathione peroxidase.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamaguchi, T | 1 |
| Sano, K | 1 |
| Takakura, K | 1 |
| Saito, I | 1 |
| Shinohara, Y | 1 |
| Asano, T | 1 |
| Yasuhara, H | 1 |
1 trial available for ebselen and Brain Vascular Disorders
| Article | Year |
|---|---|
Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-S | 1998 |